Galdeldanamycin Herbamycin A and Benzoquinone Anasamycins for Use to Prevent Neurological Damage that Results from Cardiac Arrest or Stroke
- Detailed Technology Description
- None
- *Abstract
-
The present invention provides a method of inhibiting oxidative-stress induced cell death in a cell comprising contacting the cell with a composition comprising a benzoquinoid ansamycin. The present invention further provides a method of reducing neurological injury resulting from cardiac arrest or stroke comprising administering to a patient a composition comprising a benzoquinoid ansamycin.
- *Principal Investigator
-
Name: Clifton Callaway
Department: Med-Emergency Medicine
Name: Donald DeFranco
Department: Med-Pharmacology and Chemical Biology
Name: Christopher Lipinski
Department:
Name: Nianqing Xiao
Department: Biological Sciences
- Country/Region
- USA
For more information, please click Here

